Results of SCENAR trials from the 1980's on 18,255 people with diseases of the circulation, digestion, ears, eyes, nerves musculoskeletal, respiration and urogenital systems
An overview of the BASIC RESULTS of a SCENAR Medicine Treatment Complex
A summary of Clinical Reports of Systemic Interactive Medicine Practitioners with different levels of experience each with an average of between 150 and 400 patients in each group is presented. It is important to note that in each of the following groups, the average effectiveness includes a complete recovery in an average of 2/3 and improvement in any form in about 1/3 of all cases studied using SCENAR therapy.
Diseases of the Musculoskeletal System: Arthropathies (infectious arthritis; inflammatory poliarthropathies, gout; artrosis; deformities and con-tracture of limbs, fingers and toes; derangements of knee, patella and meniscus; dislocatiocations and subluxations, pain, stiffness, effusion of joints, haemarthrosis etc.). Dorsopathies (deforming dorsopathies, scoliosis, spinal osteochondrosis, spondilolysis; spondilities and spondylosis; intervertebral disc disorders; dorsalgia, i.e.radiculopathy, cervicalgia, sciatica, lumbago etc.). Soft tissue disorders ( myositis; diastasis, paraplegia, wasting and atrophy of muscles; synovitis, bursi-tis and tendinitis; contructures, ruptures and strains of muscles and tendons; myalgia and neuralgia, pain in limbs etc.). Osteopathies and chondropathies (osteoporosis and osteomalacia; osteomyelitis; juvenile osteochondro-sis; chondromalacia etc.) Average effectiveness in this group was shown to be 79%.
Diseases of the Circulatory System: Hypertensive diseases (essential and secondary hypertension; hypertensive heart and renal diseases etc.). Ischaemic heart diseases (angina pectoris; atherosclerotic heart disease, ischemic cardiomiopathy etc.). Other forms of heart diseases (acute pericarditis; acute and subacute endocarditis and myocarditis; other cardiomyopathies; cardiac arrest; heart failure; cardialgia etc.). Cerebrovascular diseases (stroke, as intracranial haemorrhage or infarction, and its sequelae; occlusion and stenosis of cerebral and precerebral arteries; cerebral atherosclerosis etc.) Diseasers of arteries, arteriols and capillaries (atherosclerosis, incl.degeneration of blood vessels, endar-teritis deformance or obliterance; arterial embolism and thrombosis; arteriitis or endarteritis etc.). Diseases of veins (phlebitis and thrombophlebitis; varicose veins of lower extremities or elsewhere; haemorrhoids; chronic peripheral venous insufficiency etc.). Diseases of lymphatic vessels and lymph nodes ( lymphadenitis and lymphangitis; lymphoedema etc.). Hypotension. Average effectiveness in this group was shown to be 82%.
Diseases of the Respiratory System: Acute upper respiratory infections ( acute nasopharingitis –“common cold”; acute sinusitis; acute tonsillitis and pharingitis; acute laringitis and tracheitis; acute upper respiratory viral infection NOS etc.). Influenza and pneumonia (also here – acute bronchitis). Other diseases of upper respiratory tract (vasomotor and allergic rhinitis; chronic rhinitis and pharingi-tis; chronic sinusitis; abscess, furuncle and carbuncle of nose; chronic tonsillitis; peritonsillar abscess; chronic laringitis and laringotracheitis; paralysis of vocal cords and larynx; oedema of larynx and laryngeal spasm; upper respiratory tract hypersensitivity reaction etc.). Chronic lower respiratory diseases (chronic bronchitis; emphysema; chronic obstructive pulmonary diseases; asthma and status asthmaticus; bronchiectasis etc.). Other respiratory diseases (pulmonary oedema; interstitial pulmonary diseases; pneumoconiosis and hypersensitivity pneumonitis; pleural effusion; pneumothorax and haemothorax; pleuritis; acute and chronic respiratory failure etc.). Average effectiveness in this group was shown to be 84%.
Diseases of the Digestive System: Diseases of oesophagus, stomach and duodenum (oesophagitis; ulcer and dyskinesia of oesophagus; gastric and duodenal, peptic, gastrojejunal ulcers; gastritis and duodenitis, acute and chronic; dyspepsia; acute dilatation of stomach; pylorospasm etc.). Interitis and colitis. Other diseases of intestines (ileus, mostly paralytic; irritable bowel syndrome; constipation, functional diarrhoea, neurogenic bowel; anal spasm; abscess, haemorrhage or ulcer of anal and rectal regions etc.). Diseases of liver (alcoholic and toxic liver diseases; acute and chronic hepatitis; fibrosis and cirrhosis of liver; hepatic failure etc.). Disorders of gallbladder, biliary tract and pancreas (cholelithiasis and cholecystitis, acute and chronic; dyskinesia of cyst duct or gallbladder; cholangitis, spasm of sphincter of Oddi; acute and chronic pancreatitis etc.). Other diseases of digestive system (intestinal malabsorption; postgastric surgery syndromes, postoperative intestinal ofstruction and ileus, colostomy and enterostomy malfunction, postcholecystectomy syndrome etc.). Average effectiveness in this group was shown to be 93%.
Diseases of Urinary System and Male Genital Organs: Glomerular diseases (acute and chronic nephritic syndrome; recurrent and persistent heamaturia and proteinuria; nephrotic syndrome; hereditary nephropathy etc.). Renal tubulo-interstitial diseases (acute and chronic infectious interstitial nephritis, pyelitis, pyelonephritis; hydronephrosis, hydroureter and other obstructive and reflux uropathy; other nephropathies, toxic or induced by other diseases and conditions of the body). Renal failure, acute and chronic. Urolithiasis (with associated acute and chronic conditions). Other diseases of urinary tract ( cystitis, acute and chronic; neuromuscular dysfunction of bladder; ure-thritis and urethral syndrome etc.). Diseases of male genital organs (hyperplasia of prostate; acute and chronic protatitis; orchitis and epi-didymitis; male infertility etc). Average effectiveness in this group was shown to be 89%.
Disorders of Female Genital Tract; Pregnancy, Childbirth and the uerperium: Disorders of breast (benign mammary dysplasia; acute and sub-acute mastitis etc.). Inflammatory diseases of female pelvic organs (acute and chronic salpingitis and oophoritis; inflammatory diseases of uterus and cervix uteri; parametritis, pelvic cellulitis and pelvic peritonitis; inflammations of Bartholin’s gland, vagina and vulva; vulvovaginal ulceration etc.). Non-inflammatory disorders of female genital tract (endometriosis; ovarian cysts; endometrial glandular and adenomatous hyperplasia; leiomyoma of uterus; erosion, ectropion and dysplasia of cervix uteri; incompetence of cervix uteri; dysplasia of vagina and vulva; oligomenorrhoea, excessive or irregular menstruation; dysmenorrhoea and other painful conditions associated with female genital organs and menstrual cycle; menopausal and other peri-menopausal disorders; female infertility etc.). Disorders of pregnancy (complications and conditions associated with medical or spontaneous abortion and ectopic and molar pregnancy; oedema, proteinuria and hypertensive disorders; haemorrhage in early pregnancy; excessive vomiting and venous complications; infections of genitourinary tract; diabetes mellitus and liver disorders in pregnancy; pregnancy care of habitual and menace abort etc.). Complications of labour and delivery (failed induction of labour; abnormalities of forces of labour; intra-partum and postpartum haemorrhage; fetal stress and asphyxia; maternal distress and obstetric shock etc.). Complications related to the puerperium (puerperal infections; haematomas and venous complications; various complications of anaesthesia in labour and delivery; postpartum acute renal failure, cardiomyopa-thy, thyroiditis; infections of breast, cracked nipple, agalactia and hypogalactia, suppressed lactation, lac-tostasis etc.). Average effectiveness in this group was shown to be 78%.
Diseases of the Nervous System: Inflammatory diseases of the central nervous system ( meningitis, arachnoiditis, encephalitis, myelitis etc.). Demyelinating diseases of central nervous system (multiple sclerosis etc.). Episodic and paroxysmal disorders (epilepsy and epileptic syndromes; status epilepticus; migraine and other headache syndromes; transient cerebral ischaemic attacks and related syndromes; sleep disorders etc.). Nerve, nerve root and plexus disorders (disorders of trigeminal, facial and other cranial nerves; nerve root and plexus compressions and other disorders, incl. phantom limb syndrome; mononeuropathies of upper and lower limb, esp.with pain and dyskinetic syndromes etc.). Polineuropathies and other disorders of the peripheral nervous system (hereditary and idiopathic motor and sensory neuropathy; inflammatory polyneuropathy; drug-induced, alcoholic and other toxic neuropathies etc.). Diseases of myoneural junction and muscle (myastenia gravis and other myoneural disorders; muscular dystrophy, myotonic disorders, congenital and toxic myopathies; periodic paralysis; other myopathies). Cerebral palsy and other paralitic syndromes (infantile cerebral palsy; hemiplegia, paraplegia and tetraplegia etc.). Average effectiveness in this group was shown to be 81%.
Diseases of the Ear and Mastoid process: Diseases of external ear (otitis externa, incl.associated with other diseases; perichondritis etc.). Diseases of middle ear and mastoid (acute and chronic otitis media; eustachian salpingitis and obstruction; mastoiditis; disorders of tympanic membrane etc.). Diseases of inner ear ( labyrinthitis; otosclerosis; noise effects on inner ear etc.). Other disorders of ear (conductive and sensorineural hearing loss; otalgia and effusion of ear; acoustic neuritis etc.). Average effectiveness in this group was shown to be 82%.
Diseases of the Eye and Adnexa: Disorders of eyelid, lacrimal system and orbit (hordeolum and chalazion; blepharitis; ptosis of eyelid etc.; dacrioadenitis and dacryocystitis; lacrimal canaliculitis etc.; acute and chronic inflammation of orbit; exophthalmic condition as a result of haemorrhage or oedema etc.). Disorders of conjunctiva (conjunctivitis, acute and chronic)> Disorders of anterior segment of the eye (scleritis and episcleritis; keratitis, bullous keratopathy, corneal scars and opacities; acute, recurrent or subacute, and chronic anterior uveitis; hyphaema, hypopyon etc.). Disorders of posterior segment of the eye (chorioretinal inflammation; chorioretinal dystrophies and vascular disorders; maculopathies etc.). Disorders of vitreous body and globe (vitreous haemorrhage; endophthalmitis). Disorders of optic nerve (optic neuritis; papilloedema; ischemic optic neuropathy; optic atrophy etc.). Disorders of ocular muscles (strabimus and other dosorders of binocular movement). Postprocedural disorders of eye and adnexa. Average effectiveness in this group was shown to be 93%.
Diseases of Oral Cavity, Salivary Glands and Jaws: Dental caries (esp. deep and arrested). Toothache. Diseases of pulp and periapical tissues (pulpitis; acute and chronic apical periodontitis and periapical abscess; radicular cyst). Gingivitis and periodontal diseases (acute and chronic gingivitis; acute and chronic periodontitis; peri-odontosis etc.). Other diseases of jaws (odontogenic cysts; inflammatory conditions of jaws, alveolitis of jaws). Diseases of salivatory gland (sialoadenitis; abscess of salivatory gland; sialilithiasis; stenosis of salivary duct etc.). Stomatitis and related lesions.
Diseases of lips and tongue (cheilitis; cheilosis; irritative hyperplasia of oral mucosa etc.; glossitis etc.). Average effectiveness in this group was shown to be 91%.
Diseases of the Skin and Subcutaneous Tissue: Infections (staphylococcal scalded skin syndrom; impetigo; cutaneous abscess, furuncle and carbuncle; cellulitis; acute lymphadenitis; pyoderma etc.). Dermatitis and eczema (atopic dermatitis, eczema, neurodermatitis; seborrhoeic dermatitis; diaper dermatitis; allergic contact dermatitis; irritant contact dermatitis; pruritus etc.). Psoriasis, urticaria and erythema. Other skin diseses and conditions (sunburn and other radiation-related disorders; alopetia; acne and ulcer of skin etc.). Average effectiveness in this group was shown to be 68%.
Neoplasms: Benign neoplasms – SCENAR therapy was successfully applied in particular cases, mentioned above. Malignant neoplasms – SCENAR therapy was applied only as a palliative treatment; in 80% of the cases an improvement in general physical condition was achieved with the dependence on drugs removed or diminished and the patients experienced a feeling of well being.
Injury, Poisoning and certain Other Consequences of external causes: Injuries (superficial injuries – abrasion; blister; contusion, incl. bruise and haematoma; injury from superficial foreign body; insect bite, non-venomous; open wounds – animal bite; cut; laceration; puncture wound; fractures – closed, dislocated, displaced and open; dislocations, sprains and strains of joints and ligaments; injuries to nerves and spinal cord – division of nerve; haematomyelia; transient paralysis; paraplegia; quadriplegia; injuries to blood vessels; injuries to muscles and tendons; crushing injuries; injuries to internal organs etc.).
Effects of a foreign body entering through natural orifice. Burns and corrosions (thermal burns from electrical heating appliances, electricity, flame, friction, hot air and hot gases, hot objects, lightning, radiation; chemical burns, external and internal; scalds).
Frostbites. Poisoning by drugs, medicaments and biological substanses; toxic effects of substances chiefly nonmedical as to source. Other effects of external causes ( unspecified effects of radiation; effects of heat and light; hypothermia; effects of air and water pressure; asphyxiation; effects of certain deprivation, as effects of hunger, thirst; exhaustion due to exposure or excessive physical or intellectual exertion etc.; maltreatment syndromes; adverse effects, such as allergic shock and anaphylactic reactions; angioneurotic oedema; other allergies). Sequelae and complications of trauma, including surgical and other medical traumas. In all this group the application of SCENAR was shown to be extremely effective. Significant reduction of recouperating periods, in comparison with average, was observed in all the cases. Effectiveness of SCENAR therapy was proved to be in direct dependence of possibility to use the device in the earliest period after trauma.
Other applications: Certain infections and parasitic diseases (lambliasis; trichomoniasis; gonococcal and chlamidial infections; herpesviral infections with herpes symplex and herpes zoster; acute viral hepatitis A,B,C,E; chronic viral hepatitis B,C; infectious mononu-cleosis; whooping-cough; mumps; viral conjunctivitis; dermatophytosis; superfitial candidiasis; helmintiases etc.).
Diseases of the blood and disorders involving immune mechanisms (nutritional anaemias and anaemias in cases of chronic diseases; haemophilia; allergic purpura; “secondary” immuno-deficiencies, as common variable immunodeficiency, immunodeficiency with predominantly antibody defects and other major defects etc.). Endocrine, nutritional and metabolic diseases (diseases of thyroid gland – hypothyroidism, nontoxicgoitre; hyperthyroidism, thyrotoxicosis; thyroiditis, acute and chronic; diabetes mellitus; ovarian and testicular dysfunctions; localized adiposity; different kinds of metabolic disorders).
Mental and behavioral disorders (amnesia; dementia; mental and behavioural disorders due to psy-choactive substance use; affective psychosis; hysteria; mood disorders, such as depressions of different kinds etc.; neurotic disorders, such as phobias, anxiety disorders etc.; stress-related conditions, such as an acute stress reaction, post-traumatic stress disorder, adjustment disorders etc.; somatoform disorders, as such as hypo-hondriacal disorder, somatoform autonomic dysfunctions – cardiac or gastric neurosis. Neuro-circulatory asthenia, psychogenic forms of aerophagy, cough, diarrhoea, dyspepsia, pylorospasm, irritable bowel syndrome, dysuria etc., psychalgias; neurasthenia; behavioral disorders, such as eating and non-organic sleep disorders, nonorganic sexual dysfunctions etc.).
Disorders of physiological or psychological development, special behavioral and emotional disorders of childhood and adolescence (incl. childhood autism, hyperkinetic disorders, conduct and emotional disorders, disorders of social functioning, tic disorders, nonorganic enuresis, stammering etc.). Average effectiveness in this group was shown to be 81%.